Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

500 public trials 86 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Active, Not Recruiting

A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET

NCT05482971

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Marin Cancer Care Greenbrae, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 34 locations
View Trial Details
Active, Not Recruiting

Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome

NCT02521493

Conditions
Abnormalities, Multiple, Acute Myeloid Leukemia, Bone Marrow Diseases, +21 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 191 locations
View Trial Details
Active, Not Recruiting

Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms

NCT01761968

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • Charite Research Organization GmbH Berlin, Germany
  • Universitaetsklinikum Freiburg, Innere Medizin I - Haematologie und Onkologie Freiburg im Breisgau, Germany
  • Azienda Ospedaliero-Universitaria Policlinico Consorziale, Bari Bari, BA, Italy
  • Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico di Bari Bari, BA, Italy
View all 15 locations
View Trial Details
Active, Not Recruiting

Ruxolitinib vs Allogeneic SCT for Patients With Myelofibrosis According to Donor Availability

NCT03333187

Conditions
Bone Marrow Diseases, Bone Marrow Fibrosis, Hematologic Diseases, +3 more
Locations
  • Universitätsklinkum Aachen Aachen, Germany
  • HELIOS Klinikum Berlin-Buch Berlin, Germany
  • Universitätsklinikum Bonn Bonn, Germany
  • Universitätsklinikum Düsseldorf Düsseldorf, Germany
View all 14 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm

NCT04041050

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +22 more
Locations
  • City of Hope /ID# 239769 Duarte, California, United States
  • Providence - St. Jude Medical Center /ID# 242558 Fullerton, California, United States
  • Moores Cancer Center at UC San Diego /ID# 229584 La Jolla, California, United States
  • UCLA /Id# 222784 Los Angeles, California, United States
View all 42 locations
View Trial Details
Active, Not Recruiting

Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN

NCT03386513

Conditions
Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Disease Attributes, +25 more
Locations
  • Banner Health MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • UCLA Los Angeles, California, United States
  • Stanford Stanford, California, United States
View all 28 locations
View Trial Details

Related conditions